Already have an account?


Login with an existing Projects In Knowledge account Log in with your MPT account
New to Projects In Knowledge?


Register today to customize your experience.
Log In
Don't have an account yet? Click here to register



Register for Free
Already have an account? Click here to log in



Enter your current email address.  Your email address will be your user name, and where you will receive confirmation of this registration.



Forgot Password

Please Enter your email address.




  Terms & Conditions                                                                                                                                     

Privacy Policy

Projects In Knowledge is committed to protecting the privacy and confidentiality of visitors to our Web site. While Projects In Knowledge does not require that you provide us with personally identifiable information in order to visit our Web site, please note that in order to participate in the continuing medical education activities that we provide, it will be necessary for you to register with us and provide this information.

About this Privacy Policy
www.projectsinknowledge.com is our Web site for physicians and allied health care professionals, although it is open to non-professionals as well. The purpose of projectsinknowledge.com is to provide continuing medical education for healthcare professionals, and is intended for use only by a licensed healthcare professional.

Projects In Knowledge is the name we use to refer to our entire company, even though our formal corporate name is Projects In Knowledge, Inc. When we refer to ourselves as "we" or "Projects In Knowledge," we mean our company, Projects In Knowledge, Inc., including any subsidiary that we control (for example, a subsidiary that we own). We may share information among our subsidiaries that we own or control, but it is always protected under the terms of this privacy policy.

This privacy policy applies only to the Projects In Knowledge Web site. You should read the privacy policy at each Web site that you visit after you leave our site. We are not responsible for how other Web sites treat your privacy, once you leave the Projects In Knowledge site.

Privacy Policy Changes
If we change our privacy policy, we will post those changes on this page. Users should check this policy to keep abreast of any changes.

Information We Collect
In this section of our privacy policy, we discuss the different types of information we may collect about you, and the ways in which we collect them.

Information We Collect from Unregistered Visitors
Visitors to our Web site can access the Web site's home page and browse the site without disclosing any personally identifiable information. We do track information provided to us by your browser, including the Web site you came from (known as the "referring URL"), the type of browser you use, the time and date of access, and other information that does not personally identify you.

Information We Collect When You Register
Customers registering on our Web site for continuing medical education activities we provide are asked to provide us with identifying information, such as name, contact information, and other identifying information. On our registration screens, we clearly label which information is required for registration, and which information is optional and may be given at your discretion.

On our registration screens you will also find a “Burning Question” field. Submission of a “Burning Question” is completely voluntary. By submitting a “Burning Question,” you grant Projects In Knowledge the right to share it with faculty to consider as they prepare their continuing medical education presentations.

Listserves
When you are using a listserve—or member-only discussion board— on our Web site, you are posting a message and your user name, which is available for all registered members to see. You should not post any information to our listserves you want to keep private. It is a condition of our Web site that when participating in a listserve, you do not:

  • Restrict or inhibit any other user from using the listserve
  • Post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including, without limitation, any transmission constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or foreign law
  • Post or transmit any information, software or other material which violates or infringes upon the rights of others, including material which constitutes an invasion of privacy or infringement of publicity rights or which is protected by copyright, trademark or other proprietary right, or derivative works thereof, without first obtaining permission from the owner or right holder
  • Post or transmit any information, software or other material which contains a virus or other harmful component
  • Post, or transmit, or in any way exploit any information, software or other material for commercial purposes which contains advertising, promotions or marketing

By sending a message through the listserve, you grant Projects In Knowledge the non-exclusive right and license to display, copy, publish, distribute, transmit, print, and use such information. Projects In Knowledge reserves the right to terminate your access to, and use of, the listserve if you do not abide by these conditions.

Use of Cookies
Cookies are a technology used by the Projects In Knowledge Web site to identify a user as the user moves through the Web site. Your browser allows us to place some information on your computer's hard drive that identifies the computer you are using. We use cookies to track your usage throughout our Web site.

Your Web browser can be set to allow you to control whether you will accept cookies, reject cookies, or to notify you each time a cookie is sent to you. If your browser is set to reject cookies, Web sites that are cookie-enabled will not recognize you when you return to the Web site, and some Web site functionality may be lost. The Help section of your browser will tell you how to prevent your browser from accepting cookies.

Although cookies do not normally contain personally identifiable information, if you are a registered user we may associate your registration information with cookies our Web site places on your computer's hard drive. Associating a cookie with your registration data allows us to offer increased personalization and functionality. For example, you can elect to have our Web site "remember" you and bypass the registration process each time you register for one of our educational activities. Without cookies, this functionality would not be possible. Projects In Knowledge does not currently employ cookies for this use, but is considering it to make our registration processes more efficient for you.

Children's Privacy
Projects In Knowledge's Web site is designed and intended for use by adults, and is not intended for, nor designed to be used by children under the age of 18, or any other unlicensed, untrained individuals. We do not collect personally identifiable information from any person we know is a child under the age of 18.

Uses We Make of Information
In this section of our privacy policy, we identify the ways we may use information about you that we have collected.

Aggregate Data
We create aggregate data about visitors to our Web site for activity development and improvement. We also use it for market analysis. We may provide information from our Web site in aggregate form, with identifying information removed, to third parties. For example, we may tell a third party what percentage of our registered users reside in a particular geographical area. When aggregated information is provided, we pool it from many individual records and strip it of any data that could be used to identify an individual before it is used. Any third party that receives aggregated data must agree not to attempt to re-identify the people it belongs to. Projects In Knowledge does not sell any user data to any third party for commercial purposes.

Third Parties
In addition to aggregate information (discussed previously), we may share some kinds of information with third parties as described below.

  • Business Transfers: If we transfer a business unit (such as a subsidiary) or an asset (such as a Web site) to another company, we will require them to honor the applicable terms of this privacy policy.

Protection of Information
In this section of our privacy policy, we discuss the security measures we take to protect information that we have collected about you.

General Policies
We have implemented technology and security policies, rules and other measures to protect the personal data that we have under our control from unauthorized access, improper use, alteration, unlawful or accidental destruction, and accidental loss. We also protect your information by requiring that all our employees and others who have access to or are associated with the processing of your data respect your confidentiality. In addition, we have appropriate security measures in place in our physical facilities to protect against the loss or misuse of information at our site that we have collected from you.

Projects In Knowledge Employees
Projects In Knowledge employees are required to keep customer information private, as a condition of their employment with the company. Only selected, authorized Projects In Knowledge employees are permitted to access your registration information.
Employees are required to sign a confidentiality agreement. All employees and contractors must abide by our privacy policy, and those who violate that policy are subject to disciplinary action, up to and including termination of their employment and legal action.

Privacy Questions or Concerns about Our Web Site
For privacy questions or concerns about the Projects In Knowledge Web site, please contact privacy@projectsinknowledge.com.

Revision date: This policy was last updated on September 30, 2003.



New and Noteworthy
Education Initiative in Oncology

  • Breast Cancer — Survivorship Care for Postmenopausal Women With Breast Cancer – @Point of Care Chapter
  • This case demonstrates the real-life clinical scenario of a patient who has completed local treatment for hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer and is now entering the survivorship phase of cancer care. Some of the common issues that can arise in breast ... more >>
    F. Esteva, MD, PhD
  • Breast Cancer — Neoadjuvant Treatment of Locally Advanced and Early HER2-Positive Breast Cancer – @Point of Care Chapter
  • This activity from the Breast Cancer @Point of Care program presents a real-life case scenario of a woman with newly diagnosed, locally advanced, human epidermal growth factor receptor 2 (HER2)-positive breast cancer. We discuss the rationale for neoadjuvant chemotherapy and review the evidence supporting ... more >>
    K. Jhaveri, MD, FACP
  • Breast Cancer — Case Study: Management of Endocrine-Resistant Advanced HR-Positive Breast Cancer – @Point of Care Chapter
  • This case study presents a real-life case scenario of a postmenopausal woman with advanced, hormone receptor-positive, HER2-negative breast cancer who has progressed on an aromatase inhibitor. Join Dr. Jhaveri as she reviews the evidence supporting CDK4/6 inhibition in combination with fulvestrant as the ... more >>
    K. Jhaveri, MD, FACP
  • Breast Cancer — First-Line Therapy for Postmenopausal Woman With Worsening HR-positive, HER2-negative, Metastatic Breast Cancer – @Point of Care Chapter
  • This case demonstrates the real-life clinical scenario of a patient with metastatic hormone receptor (HR)-positive, HER2-negative breast cancer. Both targeted and endocrine therapies can be used for the treatment of HR-positive disease. Guideline- and evidence-based treatment strategies for patients with HR- ... more >>
    M. Chavez-MacGregor, MD, MSC
  • Hepatocellular Carcinoma — Treating Advanced Hepatocellular Carcinoma With Immunotherapy as Second-Line Therapy – @Point of Care Chapter
  • This case study in the Hepatocellular Carcinoma @Point of Care program follows a 68-year-old man with advanced hepatocellular carcinoma whose cancer progresses while receiving first-line sorafenib therapy. Safety and efficacy data for the second-line treatment options, nivolumab and regorafenib, are presented ... more >>
    G. Abou-Alfa, MD, MBA
  • Hepatocellular Carcinoma — Case Study: Diagnosis and First-Line Management of Advanced Hepatocellular Carcinoma – @Point of Care Chapter
  • This case study in the Hepatocellular Carcinoma @Point of Care follows a 57-year-old man with hepatitis C-related cirrhosis. The patient was diagnosed with advanced, unresectable hepatocellular carcinoma (HCC) and was not a candidate for transplant. This case study reviews diagnosis and first-line treatment ... more >>
    A. Singal, MD
  • Breast Cancer — Case Study: Management of ER-Negative, HER2-Positive Metastatic Breast Cancer – @Point of Care Chapter
  • This case study reviews the scenario of a woman with hormone receptor-negative, human epidermal growth factor 2 (HER2)-positive breast cancer. Patients with this subset of disease are more likely to relapse with metastatic disease within a few years of their initial diagnosis, despite adequate treatment. Join ... more >>
    K. Jhaveri, MD, FACP
  • Breast Cancer — Primary Treatment of Newly Diagnosed HR-Positive, HER2-Negative Advanced Breast Cancer – @Point of Care Chapter
  • This activity in the Breast Cancer @Point of Care program reviews a real-life case scenario of a postmenopausal woman with advanced, hormone receptor-positive breast cancer. The case demonstrates the use of cyclin-dependent kinase 4/6 inhibitors in combination with endocrine therapy as first-line therapy for ... more >>
    K. Jhaveri, MD, FACP
  • Head and Neck Cancer — Case Study: Treatment of Metastatic/Recurrent HPV-Positive Oropharyngeal Cancer – @Point of Care Chapter
  • This case illustrates the real-life clinical scenario of a patient who presents with undiagnosed metastatic human papillomavirus (HPV)-positive oropharyngeal cancer. Throughout this case the recommended treatment strategies for patients with and without HPV-positive head and neck squamous cell carcinoma will ... more >>
    J. Bauml, MD
  • Head and Neck Cancer — Case Study: Treatment of Recurrent Head and Neck Cancer After Platinum-Based Chemotherapy – @Point of Care Chapter
  • This case illustrates the real-life clinical scenario of a patient who presents with human papillomavirus (HPV)-positive oropharyngeal cancer and subsequent distant metastasis. Throughout this case the staging criteria, risk assessment, and recommended treatment strategies for patients with HPV/p16-positive, ... more >>
    R. Ferris, MD, PhD
  • Hematology Mastery in Multiple Myeloma
  • Hematology Mastery in Multiple Myeloma is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in multiple myeloma. ... more >>
    N. Raje, MD
  • Clinical Context: Gynecologic Cancers
  • Clinical Context: Gynecologic Cancers is designed to provide up-to-date information on current and emerging management strategies based on the most up-to-date evidence-based medicine and clinical trial results in gynecologic cancers. The curriculum includes case studies at the point of care and MedPage ... more >>
    B. Monk, MD, FACOG, FACS
  • Clinical Context: Prostate Cancer
  • Clinical Context: Prostate Cancer is designed to provide up-to-date information on current and emerging management strategies based on the most up-to-date evidence-based medicine and clinical trial results in prostate cancer. The curriculum includes case studies at the point of care and MedPage Today meeting ... more >>
    A. Alva, MD, MBBS
  • Clinical Context: Multiple Myeloma

  • Clinical Context: Multiple Myeloma is designed to provide up-to-date information on patient identification, symptoms, risk factors, and current and emerging treatments and best practices in the management of multiple myeloma.

    The curriculum includes four case studies at the point of care and MedPage Today ...
    more >>
    K. Anderson, MD
  • Immuno-Oncology @Point of Care: A Focus on Head and Neck Cancer
  • Primary and adjunctive treatment approaches for patients with head and neck squamous cell carcinoma are complex to navigate, requiring assessment of patient-specific risk factors, knowledge of treatment recommendations, and input from a multispecialty team. Furthermore, these patients typically have poor ... more >>
    R. Ferris, MD, PhD
  • Hepatocellular Carcinoma @Point of Care
  • This @Point of Care provides a comprehensive, continually updated resource to the clinical care team with relevant and current evidence-based medicine and clinical trial data for approved and emerging therapies to help tailor treatment based on patient characteristics in order to improve the management of ... more >>
    G. Abou-Alfa, MD, MBA
  • Chronic Lymphocytic Leukemia @Point of Care
  • Recently approved targeted therapies and emerging immunotherapies for chronic lymphocytic leukemia (CLL) are transforming patient outcomes and the standard of care. To achieve the best patient outcomes, clinicians need to implement individualized treatment plans based upon evaluation of patient ... more >>
    S. Gregory, MD
  • Multiple Myeloma @Point of Care
  • This point-of-care eHandbook delivers a thorough yet concise review of multiple myeloma (MM), its diagnosis and prognosis, and the latest evidence-based data on treatment strategies with insights from top clinical specialists on the novel and emerging therapies that are revolutionizing the management of MM. ... more >>
    S. Lonial, MD
  • Advances in Immuno-Oncology
  • Immuno-Oncology @Point of Care, featuring Jeffrey S. Weber, MD, PhD as Editor-in-Chief, is a clinical support platform that provides comprehensive information on immuno-oncology and the role of immune-based medicines in treating cancer, made up of a progressive series of chapters and other learning tools. It ... more >>
    J. Weber, MD, PhD
  • Non-Small Cell Lung Cancer @Point of Care
  • Advances in our understanding of non-small-cell lung cancer (NSCLC) are leading to new strategies for diagnosis, staging, and treatment. This point-of-care clinical resource can help you stay informed about disease pathogenesis, molecular targets, and current and emerging management strategies based on the ... more >>
    M. Socinski, MD
  • Prostate Cancer @Point of Care
  • In this subchapter, treatment of castration-resistant prostate cancer (CRPC) and resistance to the application of androgen deprivation therapy will be discussed. Links to guidelines and clinical studies throughout this chapter will increase the understanding of the approved and emerging agents for CRPC and ... more >>
    E. Crawford, MD
  • Breast Cancer @Point of Care
  • A vast body of knowledge has accumulated over the decades of research that have been conducted on the etiology and pathogenesis of breast cancer. In spite of this, the etiology and underlying causes of breast cancer are not well-understood. This chapter will examine risk factors for breast cancer as well as ... more >>
    F. Esteva, MD, PhD
  • Multiple Myeloma — High-Risk Relapsing MM: Retreatment With Immunomodulatory Therapy – Case Study
  • Determination of the best treatment for a high-risk multiple myeloma patient is based on a complex set of factors, including risk evaluation, patient comorbidities, patient desires, and the need to achieve a satisfactory response as quickly as possible. In this case, Dr. Lentzsch discusses the problems ... more >>
    S. Lentzsch, MD, PhD
  • Multiple Myeloma — Relapsing/Refractory Multiple Myeloma in a High Risk Patient: Efficacy With Monoclonal Antibody Therapy as Part of Triple Therapy – Case Study
  • Choosing the appropriate therapy for transplant-deferred patients with relapsed multiple myeloma (MM) can be challenging; there are now emerging combination treatments available, each with their own efficacy and safety profiles. This case illustrates the real-life case scenario of a patient with relapsed MM ... more >>
    N. Raje, MD
  • Prostate Cancer — Progressive Metastatic Castrate-Resistant Prostate Cancer – Case Study
  • While prostate cancer is often curable with local treatment, many patients will develop recurrence with metastatic castration-resistant prostate cancer (mCRPC). Several targeted treatments are available for mCRPC, and enrollment into clinical trials plays an important role in management of recurrent disease ... more >>
    T. Dorff, MD
  • Prostate Cancer — Newly Diagnosed Metastatic Prostate Cancer Patient – Case Study
  • This activity reviews a real-life case scenario of a patient with newly diagnosed metastatic hormone-sensitive prostate cancer who was found to have bone metastases. The case reviews available treatment options and highlights the importance of choosing a treatment option based on available clinical data and ... more >>
    N. Agarwal, MD
  • Multiple Myeloma — Treatment of a Relapsing High-Risk Multiple Myeloma Patient – Case Study
  • Today there are many options for the treatment of patients with relapsed multiple myeloma, as well as more treatments in development. This case illustrates the real-life scenario of a patient with relapsed multiple myeloma with evolution of his disease at the time of relapse introducing a high-risk ... more >>
    S. Kumar, MD
  • Prostate Cancer — Castration-Resistant Prostate Cancer Patient with Bone Metastases – Case Study
  • This case reviews a real-life case scenario of a patient with castration-resistant prostate cancer who is experiencing bone pain associated with his bone metastases. The case reviews available treatment options and highlights the importance of choosing a treatment based on efficacy and safety of available ... more >>
    A. Alva, MD, MBBS
  • Multiple Myeloma — Treatment of a Patient with Relapsed/Refractory Multiple Myeloma and No Comorbidities – Case Study
  • Today there are multiple options for the treatment of patients with relapsed or refractory multiple myeloma, as well as further treatments in development. This case illustrates the real-life scenario of a patient with relapsed, bortezomib-refractory multiple myeloma, and discusses the treatment options ... more >>
    S. Bringhen, MD, PhD
  • Gynecologic Cancers — Treatment of Recurrent Stage IIIB Cervical Adenoma – Case Study
  • This case illustrates the real-life scenario of a woman with cervical adenocarcinoma that recurs outside of the initial treatment field following initially successful definitive chemoradiation treatment. Treatment with systemic chemotherapy is warranted in such circumstances, but various options and ... more >>
    R. Coleman, MD
  • Multiple Myeloma — Role of Proteasome Inhibitor Therapy in a Patient with High-Risk Relapsing Multiple Myeloma – Case Study
  • High-risk multiple myeloma is challenging to manage, as these patients tend to have aggressive disease, transient responses to treatment, and short overall survival. This case illustrates the real-life scenario of a patient with high-risk multiple myeloma and disease progression after initial treatment with ... more >>
    J. Shah, MD
  • Gynecologic Cancers — Treatment of a Patient with Platinum-Resistant Recurrent Ovarian Cancer – Case Study
  • Although progress has been made in the treatment of ovarian cancer, the majority of patients still experience disease recurrence. More and more frequently, these patients receive multiple lines of treatment. This case illustrates the real-life scenario of a woman who experiences multiple recurrences of her ... more >>
    R. Coleman, MD